RecallRadar

FDA Drug recall D-0622-2017

Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc…

On 2017-04-05 the FDA classified a Class II recall of Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc… by Mylan Institutional D B A Udl Laboratories, citing microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0622-2017
ClassificationClass II
Statusterminated
Initiated2017-03-21
Published2017-04-05
Last updated2026-09-13 11:51 UTC
CompanyMylan Institutional D B A Udl Laboratories
DistributionUS

Product

Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20

Reason

Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.

Identifiers

ndc51079-208-01
ndc51079-208-20
ndc51079-209-01
ndc51079-209-20
ndc51079-210-01
ndc51079-210-20
ndc51079-211-01
ndc51079-211-03
code_infoLot #: 3084288, Exp. 07/18

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0622-2017%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.